| Serial Number | 98048406 |
| Word Mark | MEDPRO SYSTEMS |
| Filing Date | Monday, June 19, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 2, 2024 |
| Registration Number | 7432933 |
| Registration Date | Tuesday, July 2, 2024 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 16, 2024 |
| Goods and Services | Consulting services in the nature of conducting trainings for life sciences, pharmaceuticals, biotechnology, and medical device companies personnel and partners on pharmaceutical and medical device compliance program requirements, fraud and corruption laws and regulations, industry codes and best practices; consulting services, namely, developing and providing trainings for life sciences, pharmaceutical, biotechnology, and medical device companies in the field of corporate compliance and transparency programs |
| Description of Mark | The mark consists of a rectangle consisting of two interlocking puzzle pieces. The puzzle piece on the left is gray and contains the word "MEDPRO" in white, and the puzzle piece on the right is navy blue and contains the word "SYSTEMS" in white. |
| Indication of Colors claimed | The colors blue, gray and white are claimed as a feature of the mark. |
| Goods and Services | Business consulting services for life sciences, pharmaceuticals, biotechnology and medical device companies in the nature of regulatory compliance program development and enhancement and transparency program support, namely, reviewing program status and performing gap analyses, drafting programs plans, program implementation support, development and improvement of policies, standard operating procedures and codes of conduct; business consulting services in the nature of monitoring of pharmaceutical and medical device manufacturer interactions with healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of auditing of pharmaceutical and medical device manufacturer interactions with and payments to healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of business investigation support for internally and externally raised complaints made against a pharmaceutical or medical device manufacturer related to potential violations of their company policy or code, industry code, or law or regulation; transparency reporting regulatory submission management, namely, assisting others in preparing and filing regulatory submissions in the field of transparency reporting for pharmaceutical, biotechnology and medical device companies; business consulting services, namely, tracking and monitoring regulatory requirements for others in the field of life sciences, pharmaceuticals, biotechnology, and medical devices for regulatory compliance; business consulting services, namely, compliance program gap analysis for life sciences, pharmaceutical, biotechnology, and medical device companies |
| Goods and Services | Regulatory compliance consulting in the field of life sciences, pharmaceuticals, biotechnology, and medical devices; consulting services to assist life sciences, pharmaceutical, biotechnology and medical device companies in the fields of regulatory compliance, namely, compliance in the areas of aggregate spend disclosure reporting, the Prescription Drug Marketing Act, the Drug Supply Chain Security Act, Condition of Participation for Outpatient Services, Stark Law and Ohio Terminal Distributor of Dangerous Drugs requirements; regulatory compliance audits for life sciences, pharmaceutical, biotechnology and medical device companies to assist with regulatory compliance; consulting services in the field of life sciences, pharmaceutical, biotechnology and medical device corporate compliance program and transparency program development, implementation and support; providing online searchable databases and information concerning historical, current and pending laws, regulations, and guidance documents governing the life sciences industry; regulatory compliance consulting services in the field of aggregate spend disclosure reporting; regulatory and compliance information for pharmaceutical, biotechnology and medical device companies, and for entities involved in the drug and device supply chain, regarding transparency and aggregate spend, marketing, and additional compliance requirements; regulatory compliance consulting, namely, reviewing, developing, training on and assisting with the implementation and monitoring of standards, practices, procedures and policies to support regulatory compliance for companies in the fields of life sciences, pharmaceuticals, biotechnology, and medical devices |
| NOT AVAILABLE | "SYSTEMS" |
| Goods and Services | Software as a service (SaaS) services featuring software for use to assist in tracking and reporting healthcare practitioner and healthcare organization interactions and complying with international, federal, state and local spend and transparency laws and regulations; software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies in managing, validating and enriching healthcare organization and healthcare practitioner data attributes in connection with regulatory compliance, sales and marketing efforts |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 21, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | Thursday, April 1, 2021 |
| First Use In Commerce Date | Thursday, April 1, 2021 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 21, 2023 |
| Primary Code | 041 |
| First Use Anywhere Date | Thursday, April 1, 2021 |
| First Use In Commerce Date | Thursday, April 1, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 21, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, February 11, 2003 |
| First Use In Commerce Date | Tuesday, February 11, 2003 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 21, 2023 |
| Primary Code | 045 |
| First Use Anywhere Date | Thursday, April 1, 2021 |
| First Use In Commerce Date | Thursday, April 1, 2021 |
| Party Name | MedPro Systems LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Mt. Arlington, NJ 07856 |
| Party Name | MedPro Systems LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Mt. Arlington, NJ 07856 |
| Party Name | MedPro Systems LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Mt. Arlington, NJ 07856 |
| Event Date | Event Description |
| Thursday, June 22, 2023 | NEW APPLICATION ENTERED |
| Friday, July 21, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, July 22, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, February 26, 2024 | ASSIGNED TO EXAMINER |
| Friday, March 1, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, March 1, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, March 1, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 5, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, March 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 11, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 27, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 16, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 16, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 2, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 2, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |